Skip to main content

For Biopharma

Education & events

Articles  -  4 June 2024

Cell and Gene Therapy Answers: What to know about companion diagnostics development

Search our knowledge library

Recent

Posters & publications

Posters  —  3 April Apr 2025

Mutational profiles of pancreatic cancer patients from eastern Asia using paired germline and somatic exome sequencing. Ruether J et al. AACR2025

Read More about Mutational profiles of pancreatic cancer patients from eastern Asia using paired germline and somatic exome sequencing. Ruether J et al. AACR2025
Posters  —  3 April Apr 2025

Orthogonal confirmation using the Pacbio® two step universal adapter amplicon protocol to validate a comprehensive genomic profiling assay for hematologic malignancies. Hogg G et al. AACR2025

Read More about Orthogonal confirmation using the Pacbio® two step universal adapter amplicon protocol to validate a comprehensive genomic profiling assay for hematologic malignancies. Hogg G et al. AACR2025
Posters  —  3 April Apr 2025

Pharmacogenomic landscape of UGT1A1 in cancer patients from the Avera sequencing and analytics protocol (ASAP) registry. Amoah K et al. AACR2025

Read More about Pharmacogenomic landscape of UGT1A1 in cancer patients from the Avera sequencing and analytics protocol (ASAP) registry. Amoah K et al. AACR2025

Trending

Scientific Topics

Info Sheets  —  23 July Jul 2024

Labcorp Bioanalytical Services Antibody Drug-Conjugate (ADC) Services

Read More about Labcorp Bioanalytical Services Antibody Drug-Conjugate (ADC) Services
Info Sheets  —  23 July Jul 2024

Antibody drug-conjugates (ADCs): Analytical considerations for QC release, stability testing, characterization and comparability

Read More about Antibody drug-conjugates (ADCs): Analytical considerations for QC release, stability testing, characterization and comparability
Articles  —  14 May May 2024

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)

Read More about Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)